Padliya
Dilipkumar Padliya, Beaumont, TX US
Patent application number | Description | Published |
---|---|---|
20150107373 | Apparatus and Process for Measuring the Friability of Polymer Bales - A process for measuring the friability of a material, such as a polymer bale, may include measuring the amount of force required to break-up a portion of the material. A corresponding testing apparatus for measuring the friability may include a device configured for breaking-up the portion of the material and measuring the force required to cause the break-up to occur. | 04-23-2015 |
Neerav Padliya, Scotch Plains, NJ US
Patent application number | Description | Published |
---|---|---|
20130315875 | AMNION DERIVED ADHERENT CELLS - Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals. | 11-28-2013 |
Neerav Padliya, South Grafton, MA US
Patent application number | Description | Published |
---|---|---|
20150238566 | METHOD OF OBTAINING EFFECTIVE AMOUNTS OF AVIAN FOLLISTATIN - Embodiments of the present invention are generally related to methods of obtaining effective amount of avian follistatin. More specifically, embodiments of the present invention relate to products comprising avian follistatin, and methods of optimizing the same based on avian follistatin concentrations utilized during the manufacturing process. In one embodiment of the present invention, a method of creating a consumable product for treatment of a muscle degenerating disease having avian follistatin comprises selecting an avian egg based upon a desired threshold of avian follistatin concentration therein; extracting material from the avian egg, the material comprising avian follistatin; and processing the material with one or more excipients to yield the consumable product. | 08-27-2015 |
Neerav D. Padliya, Scotch Plains, NJ US
Patent application number | Description | Published |
---|---|---|
20100124569 | AMNION DERIVED ADHERENT CELLS - Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals. | 05-20-2010 |
20110250182 | ANGIOGENESIS USING PLACENTAL STEM CELLS - Provided herein are methods of treating individuals having diseases or disorders of the circulatory system, using placental cells, e.g., the placental stem cells and placental multipotent cells (PDACs) described herein, and populations of such placental cells. The invention also provides methods of angiogenesis using such cells or populations of cells comprising such cells. | 10-13-2011 |
Neerav Dilip Padliya, Scotch Plains, NJ US
Patent application number | Description | Published |
---|---|---|
20090252710 | TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS - Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells. | 10-08-2009 |
20140093488 | TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS - Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells. | 04-03-2014 |